Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program

Figure 1

Progression-free and overall survival of the cohort according to the number of lines. A: Progression-free survival in the whole cohort. B: Progression-free survival of patients treated in first (blue), second (green), third (light brown) or >3 (purple) line of treatment (log-rank, p = 0,043). C: Overall survival in the whole cohort. D: Overall survival of patients treated in first (blue), second (green), third (light brown) or >3 (purple) line of treatment (logrank, p = 0,018).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us